PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

Journal of Clinical Endocrinology Metabolism

1 Papers Indexed in Blossom

Data updated October 28, 2025

Research Footprint

Journal of Clinical Endocrinology Metabolism has 1 tracked paper indexed in Blossom (2011) from 3 authors, most often covering MDMA, across Healthy Volunteers, Palliative & End-of-Life Distress and Depressive Disorders.

Published Papers

Open Accessindividual

Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects

In a randomised placebo‑controlled crossover study, MDMA (125 mg) significantly raised plasma copeptin—a stable surrogate for AVP—in women but not men, with a nonsignificant AVP rise and evidence of increased renal water retention. These effects were blocked by duloxetine, implicating MDMA‑induced serotonin and noradrenaline release in the sex‑specific AVP/copeptin response and offering a mechanism for the higher incidence of hyponatraemia in female ecstasy users.

Published
September 1, 2011
Journal
Journal of Clinical Endocrinology Metabolism
Authors
Simmler, L. D., Hysek, C. M., Liechti, M. E.

Quick Facts

Papers Indexed
1
Publisher
The Endocrine Society
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.